WD-40 Stock Dip: 5 Reasons to Stay Bullish

by mark.thompson business editor

WD-40 Stock Presents Buying Opportunity After Q1 2026 Sell-Off, Analysts Say

Despite a recent market reaction to its fiscal Q1 2026 earnings, WD-40 remains a compelling investment for total return seekers, according to a new analysis of the company’s performance. While the stock experienced a sell-off following the report, several key fundamentals suggest the downturn may represent a significant buying opportunity. Despite coming in below analyst expectations, the company’s long-term trajectory appears intact, supported by a healthy dividend and robust institutional ownership.

Revenue Growth Remains a Key Strength

The initial market response to the WD-40 report was driven by growth figures that fell short of expectations. Top-line revenue reached $154.4 million, representing less than 1% growth, largely attributable to foreign exchange conversion. On an FX-neutral basis, revenue actually declined by over 2%. However, a deeper dive reveals promising underlying trends. “The critical detail is that growth is present,” one analyst noted, pointing to temporary factors like the timing of distributor orders and the strength of direct market sales as mitigating influences.

Notably, direct market sales surged by 8%, fueled by gains in the Americas, EIMEA regions, and the Specialty products segment. The company anticipates that softness in indirect markets will normalize as the year progresses, paving the way for stronger overall revenue performance.

Expanding Margins Signal Future Profitability

Despite the revenue headwinds, WD-40 demonstrated improved profitability. Gross margin expanded by 140 basis points, signaling positive operating leverage as revenue recovers. A 10% increase in SG&A expenses was largely attributed to non-recurring charges with minimal impact on cash flow. The company maintained a strong free cash flow margin of 17.5%, enabling continued capital returns to shareholders through dividends and share repurchases.

Confident Outlook for Fiscal 2026 and Beyond

Even with the weaker-than-expected Q1 results, WD-40 reaffirmed its full-year guidance for fiscal 2026. The company currently projects revenue growth of 5% to 9%, with operating income and earnings expected to follow suit. Looking further ahead, the company believes it has only reached 25% saturation of its target market, presenting the potential to quadruple in size over time.

This long-term growth potential suggests the current price-to-earnings multiple of 34x in early 2026 may be undervalued. In a scenario where the company realizes its full potential, it could effectively trade at a multiple of only 10x, indicating a deep value proposition. “

Consistent Capital Returns Enhance Shareholder Value

WD-40’s commitment to returning capital to shareholders remains strong. The company’s dividend yield currently exceeds 2%, based on the stock’s price near recent lows, and represents approximately 60% of forecasted earnings. The dividend has been increased annually for 17 consecutive years, with the latest increase exceeding 8%. Future dividend increases are expected to align with earnings growth.

Furthermore, WD-40 repurchased over $20 million in shares during fiscal 2025 and plans to accelerate buyback activity in 2026. Q1 repurchases totaled over $7.5 million, contributing to a slight decrease in the outstanding share count.

Institutional Support Provides a Price Floor

Institutional investors, representing over 90% of WD-40’s ownership, have demonstrated strong support for the stock. After a period of selling in the latter half of 2025, institutions resumed buying, coinciding with the market bottom. This shift suggests a price floor is in place, likely to hold in early 2026.

While some price retracement to the long-term moving average near $175 is possible, analysts do not anticipate lower lows. The consensus view is that the stock will continue to stabilize around early January levels before regaining upward momentum later in the year.

You may also like

Leave a Comment